21.12.2020
•
News
Real estate and construction
Tax
KŠB Advises J&T Banka on HQ Acquisition
KŠB team advised J&T Banka on the acquisition of Rustonka Development II, which owns the Rustonka office building in Karlín, Prague, with over 17,900 m2 of leasable area. In September 2020, the bank moved its headquarters to the building together with approximately 750 employees. The value of the transaction is approximately EUR 80 million.
KŠB’s advice included a comprehensive due diligence and negotiating and drafting the transaction documentation. The KŠB team was led by Jiří Horník (partner) and Josef Kříž (senior associate), who were further assisted by Jan Černohouz (tax advisor) and Filip Šperl, Lukáš Weiss and Ondřej Siška (junior associates).
More information is available here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
